603351.SH
Nanjing Well Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 27.45
+5.54%Margins
Gross margin
28.8%
EBITDA margin
22.1%
EBIT margin
13.0%
Net margin
11.3%
FCF margin
13.9%
8.3%
Return on equity
5.8%
Return on assets
7.3%
Return on invested capital
0.51x
Asset turnover
CNY 233.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026